eISSN: 3023-6940
  • Home
  • External Validation of CROES Stone Score System to Predict Treatment Success and Complications of Percutaneous Nephrolithotomy

Original Research

External Validation of CROES Stone Score System to Predict Treatment Success and Complications of Percutaneous Nephrolithotomy


1 Doç. Dr. Yaşar Eryılmaz Doğubayazıt Devlet Hastanesi, Üroloji Kliniği, Ağrı, Türkiye

2 Sağlık Bilimleri Üniversitesi Bozyaka Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye


DOI : 10.33719/yud.582491
New J Urol. 2019; 14 (2): 81-90

Abstract

Introduction: To validate CROES scoring system for predict treatment success and compli- cation rates of patients who underwent percutane- ous nephrolithotomy (PNL).

Material and Methods: We retrospectively analysed 568 patients who underwent PNL from January 2012 to August 2015 at Izmir Bozyaka Research and Training Hospital Urology Depart- ment. Sixty-one patients who had more than one access were excluded from the study. All patients evaluated with non-contrast spiral computed to- mography (CT) scan before operation.

Stone-free status was assessed on 1-month postoperative visit using kidney-ureter-blad- der (KUB) radiograph. CT is reserved for only symptomatic patients, radiolucent stones, and/or suspicion of residual fragments seen on KUB ra- diography. Residual stone size of <4 mm on KUB or CT was described as clinically insignificant re- sidual fragments, and these patients were conside- red as stone free.

All patients were evaluated one by one with CROES scoring system. Stone-free status, ope- ration time, fluoroscopy time, length of hospital stay and estimated blood loss were correlated with CROES score. Postoperative complications were scored with Modified Clavien scoring systems and correlated with CROES score.

Results: The mean CROES score was 203,70. Overall stone free rates was %77,9. The mean stone size was 502,01 ± 517,5 (55-2869) mm². 112 (%22,1) of the patients had residue stone. 159(32,5%) patients experienced postoperative complications.

There was positive correlation between CRO-ES stone scoring system with stone-free rates (p<0,001) and negative correlation with complication rates (p<0,001). There was negative cor- relation with statistically significant between CROES scoring system with operative time (p<0,001), stone burden (p<0,001), estimated blood loss (>250 mL) (p=0,007) and length of hospital stay (p=0,026). CROES score was found to be independent predictor of SFR in a multivariate logistic regression analysis. (p<0,001). CROES score was not an inde- pendent factor for predicting complication.

Conclusion: In the present study, we demonstrated that CROES scoring system can be effectively and reliably used to predict SFR after PCNL. Also, CROES was effective to predict postoperative complicati- ons. This scoring system can guide the clinician to predict perioperative and postoperative PCNL outcomes.

Keywords: Percutaneous Nephrolithotomy, CROES scoring systems, Modification Clavien score system


Abstract

Introduction: To validate CROES scoring system for predict treatment success and compli- cation rates of patients who underwent percutane- ous nephrolithotomy (PNL).

Material and Methods: We retrospectively analysed 568 patients who underwent PNL from January 2012 to August 2015 at Izmir Bozyaka Research and Training Hospital Urology Depart- ment. Sixty-one patients who had more than one access were excluded from the study. All patients evaluated with non-contrast spiral computed to- mography (CT) scan before operation.

Stone-free status was assessed on 1-month postoperative visit using kidney-ureter-blad- der (KUB) radiograph. CT is reserved for only symptomatic patients, radiolucent stones, and/or suspicion of residual fragments seen on KUB ra- diography. Residual stone size of <4 mm on KUB or CT was described as clinically insignificant re- sidual fragments, and these patients were conside- red as stone free.

All patients were evaluated one by one with CROES scoring system. Stone-free status, ope- ration time, fluoroscopy time, length of hospital stay and estimated blood loss were correlated with CROES score. Postoperative complications were scored with Modified Clavien scoring systems and correlated with CROES score.

Results: The mean CROES score was 203,70. Overall stone free rates was %77,9. The mean stone size was 502,01 ± 517,5 (55-2869) mm². 112 (%22,1) of the patients had residue stone. 159(32,5%) patients experienced postoperative complications.

There was positive correlation between CRO-ES stone scoring system with stone-free rates (p<0,001) and negative correlation with complication rates (p<0,001). There was negative cor- relation with statistically significant between CROES scoring system with operative time (p<0,001), stone burden (p<0,001), estimated blood loss (>250 mL) (p=0,007) and length of hospital stay (p=0,026). CROES score was found to be independent predictor of SFR in a multivariate logistic regression analysis. (p<0,001). CROES score was not an inde- pendent factor for predicting complication.

Conclusion: In the present study, we demonstrated that CROES scoring system can be effectively and reliably used to predict SFR after PCNL. Also, CROES was effective to predict postoperative complicati- ons. This scoring system can guide the clinician to predict perioperative and postoperative PCNL outcomes.

Keywords: Percutaneous Nephrolithotomy, CROES scoring systems, Modification Clavien score system